190.60MMarket Cap
12.25P/E TTM
Protalix Biotherapeutics Inc
PLX Balance Sheet
You can check out the annual or quarterly balance sheets of Protalix Biotherapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing PLX stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Protalix Biotherapeutics Inc Have?
In its most recent quarterly, Protalix Biotherapeutics Inc had 41.00M in cash and cash equivalents.
How Much Are Protalix Biotherapeutics Inc's Total Liabilities?
Protalix Biotherapeutics Inc reported 34.12M in total liabilities as of the latest reported quarter, including 26.52M in current liabilities and 7.60M in non-current liabilities.
What Are Protalix Biotherapeutics Inc's Total Assets?
As of the latest reported quarter, Protalix Biotherapeutics Inc's total assets were 82.35M, consisting of 66.67M in current assets and 15.67M in non-current assets.
How Much Shareholders' Equity Does Protalix Biotherapeutics Inc Have?
Protalix Biotherapeutics Inc reported 48.23M in total shareholders' equity as of the latest reported quarter.